Why is an infection control program needed in the hemodialysis setting?

Area of Science:

• Nephrology
• Infectious Diseases
• Public Health

Background:

• Infections are the second leading cause of mortality in end-stage renal disease (ESRD) patients.
• Sepsis, particularly from vascular access sites, contributes significantly to mortality in hemodialysis patients.
• Hemodialysis patients are at high risk for antimicrobial resistance, including VRE, MRSA, VISA, and VRSA.

Purpose of the Study:

• To emphasize the critical importance of infection control recommendations in hemodialysis.
• To highlight strategies for preventing antimicrobial resistance in dialysis patients.
• To underscore the need for meticulous vascular access care to improve patient outcomes.

Main Methods:

• Review of infection control and antimicrobial resistance prevention strategies in hemodialysis.
• Emphasis on the four key strategies of the campaign to prevent antimicrobial resistance in dialysis: prevent infection, diagnose and treat infection, use antimicrobials wisely, and prevent transmission.
• Focus on practical measures such as avoiding hemodialysis catheters when possible and diligent care of all vascular access sites.

Main Results:

• Sepsis accounts for approximately 11% of mortality in hemodialysis patients.
• Adherence to infection control recommendations is vital for this vulnerable population.
• Proactive infection prevention and antimicrobial stewardship can reduce hospitalizations and mortality.

Conclusions:

• Implementing comprehensive infection control measures is essential to reduce mortality and morbidity in hemodialysis patients.
• Minimizing catheter use and ensuring meticulous vascular access care are key components of infection prevention.
• Effective strategies against antimicrobial resistance are critical for improving the quality of life for patients undergoing hemodialysis.